GBC’s Don Fry praises governor’s $1.1 billion bioscience plan for Maryland

Greater Baltimore Committee president and CEO Donald C. Fry praised Governor Martin O’Malley’s proposal to quadruple the amount of Maryland’s available biotech investment tax credits by 2013 and to invest $1.1 billion over the next 10 years to grow the state’s bioscience industry. Other elements of O’Malley’s “Bio 2020”...

UMB BioPark growing; celebrates Building Two grand opening

More than 300 business and government leaders joined the community and campus on March 31 to celebrate the growth of the University of Maryland BioPark with the opening of Building Two and the launching of Building Three. The themed celebration, “Watch Us Grow – in square feet, community impact, and in bioscience collaborations,” was held under a tent in the center of the BioPark. “This marks another milestone in the … Continue reading

Greater Baltimore Committee awards three CEOs and university president at 2008 Baltimore Region Bioscience Awards Ceremony

Three biotech CEOs and the president of one of the area’s major research universities were honored today by the Greater Baltimore Committee as winners of the region’s third bioscience award competition. Winners of the 2008 Greater Baltimore Region Bioscience Awards are: Best New Product or Progress: Timothy E. Askew, president and CEO, CSA Medical, Inc. Askew’s very young Baltimore-based company has developed a breakthrough product incorporating a new medical device … Continue reading

Greater Baltimore Committee to announce winners of third Baltimore region Bioscience Awards

More than 140 leaders from the Baltimore region’s bioscience industry and research community will attend a breakfast reception at the Greater Baltimore Committee to honor winners of the 2008 Greater Baltimore Region Bioscience Awards. This is the third annual awards event presented by the Greater Baltimore Committee, the region’s most prominent organization of business and civic leaders, to recognize outstanding achievements in the region’s bioscience industry. The Greater Baltimore Committee … Continue reading

GBC’s Fry: Maryland�s maturing bioscience industry

Don Fry Commentary on WYPR Maryland’s young bioscience industry is growing up. It’s not yet mature, but significant signs of growth are there. This spring Baltimore will gain 450,000 square feet of bioscience lab and office space as UMB BioParks’ second building opens in March on the city’s west side, and the first bioscience building at the Science + Technology Park at Johns Hopkins on the east side opens in … Continue reading

GBC seeks nominations for region’s third annual Bioscience Awards

The Greater Baltimore Committee is seeking nominations for the third annual Greater Baltimore Region Bioscience Awards to be held on March 18. Nominate a company or individual for an award. The four award categories are: Entrepreneurial, Best New Product or Progress, Leadership in Bioscience and President’s Award. Nominators will be asked to submit documentation and narratives that fulfill several criteria and then to add other supporting evidence as deemed suitable. … Continue reading

Baltimore set to get 450,000 square feet of new lab space this spring

This spring, Baltimore will gain more than 450,000 square-feet of bioscience lab and office space as each the city’s two developing bioscience and technology parks opens a new building, managers of the two parks announced at the Greater Baltimore Committee’s first bioscience event of year on January 15. In March, the UMB BioPark on the city’s west side will open its second building, a 220,000 square-foot facility on West Baltimore … Continue reading

Van Hollen: Maryland “well positioned” in bioscience industry

The state of Maryland is well positioned to move forward in the bioscience industry and to compete at a national level, said Congressman Chris Van Hollen. “We need greater cross pollination… and to create opportunities for symbiotic relationships.” More than 300 bioscience companies are located in Maryland, Van Hollen told GBC members at a Bioscience Speaker Series lecture on July 18. More than 25,000 jobs relate directly to the biotech … Continue reading

Paterson named GBC bioscience committee chair

The Greater Baltimore Committee today announced that Blake Paterson, M.D., founder and CEO of Alba Therapeutics, one of the fastest growing and most successful bioscience companies in the region, will chair the GBC’s Bioscience Committee. Dr. Paterson was asked to chair the committee because of his experience with start-up bioscience companies, his acknowledged leadership in the industry and his interest in affecting legislation that will benefit bioscience companies in Maryland. … Continue reading

Report cites need to expand BioTechnical Institute’s bioscience workforce training

A recent report by the University of Baltimore urges the continued expansion of the BioTechnical Institute of Maryland, Inc. (BTI), a Baltimore nonprofit that trains city residents who are high school graduates and places them in biotech industry jobs. The report evaluates the workforce development programs of BTI, which was founded in 1998 by a Johns Hopkins geneticist to offer tuition-free training for jobs in Maryland’s expanding biotech industry. Bioscience … Continue reading